Aktie A12GNG ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Aktien

A12GNG

CNE100001TG0

603168

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 08.05.2024 		% 5 Tage % 1. Jan.
8,99 CNY -1,10 % Intraday Chart für Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. +1,35 % -32,96 %
29.04. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
19.04. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shapuaisi Pharma Gets China's Nod to Market Sodium Hyaluronate Eye Drops
Shapuaisi Pharma Gets Marketing Authorization for Moxifloxacin Hydrochloride Eye Drops
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Lechun Biotechnology Co., Ltd. sign a share transfer agreement to acquire a 14.5% stake in Advanced Sterile Solutions Biotechnology Co., Ltd. from Shanghai Changgeng Industrial Development Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 40.6 million.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Taizhou Women and Children's Hospital Co., Ltd. announced that it expects to receive CNY 231.1828 million in funding from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. agreed to acquire Qingdao Shikang Eye Hospital Co., Ltd. from Shanghai Fangzhi Medical Management Co., Ltd. for CNY 66.5 million
Zhejiang Shapuaisi Pharma Shareholder Boosts Stake Through $44 Million Deal
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it has received CNY 317.999993 million in funding from Shanghai Yanghe Investment Management Co., Ltd. and other investor.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Shanghai Yanghe Industrial Co., Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shanghai Tonghui Medical Management Co., Ltd. completed the acquisition of 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A12GNG Aktie
  4. Nachrichten Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
  5. Andere Sprachen